@tech.eu 4 years ago
Kheiron’s $22 million Series A funds early breast cancer detection for women worldwide
@venturebeat.com 8 years ago
Solace Therapeutics Completes Enrollment of the SUCCESS Clinical Trial for the Vesair® Bladder Control System for Stress Urinary Incontinence